Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
56°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Pfizer
(NY:
PFE
)
26.22
-0.10 (-0.38%)
Streaming Delayed Price
Updated: 12:49 PM EDT, Apr 24, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Pfizer
< Previous
1
2
...
29
30
31
32
33
34
35
36
37
...
99
100
Next >
The Top 7 Underrated Dividend Stocks Yielding 3% or More
September 19, 2023
Investors seeking dependable income and upside should buy these dividend stocks yielding 3% or more, the sooner the better
Via
InvestorPlace
European Commission Approves Pfizer’s LITFULO™ for Adolescents and Adults With Severe Alopecia Areata
September 19, 2023
From
Pfizer Inc.
Via
Business Wire
2 Stocks That Sank Hard on Monday
September 18, 2023
Investors were generally in wait-and-see mode, but not with certain individual stocks.
Via
The Motley Fool
Is This 250-Year-Old Japanese Big Pharma Giant Selling For Half Price Right Now?
September 18, 2023
When it comes to Big Pharma, Japan’s Takeda Pharmaceutical Co Ltd (NYSE: TAK) is a conservative play that could prove to be a big winner given its cheap valuation and suite of new drugs that portend to...
Via
Benzinga
Looking At Pfizer's Recent Unusual Options Activity
September 14, 2023
Via
Benzinga
Pfizer Invites Public to View and Listen to Webcast of October 31 Conference Call with Analysts
September 18, 2023
From
Pfizer Inc.
Via
Business Wire
First Human Clinical Trials Of A Potentially "Game-Changing Broad Spectrum Antiviral" Are Progressing Successfully – Drug Could Treat COVID, RSV And Many Other Respiratory Viruses
September 18, 2023
As COVID cases begin to rise again, heralding the beginning of another COVID wave, new variants have appeared leading this wave. EG.5 (“Eris”) is currently in the majority in the U.S.A, but a very...
Via
Benzinga
Exposures
COVID-19
Can These 3 Healthcare Dividend Stocks Deliver Income Growth?
September 18, 2023
Healthcare-sector dividend payers Pfizer, Medtronic, and Gilead all boosted shareholder payouts and trade at low multiples relative to potential price gains.
Via
MarketBeat
Financial Crime Weekly: Pfizer Statistician's $214,000 Trade Leads To Charges
September 15, 2023
Amit Dagar, once a trusted statistician for pharmaceutical behemoth Pfizer Inc (NYSE: PFE), and Atul Bhiwapurkar, his close business ally, now find themselves mired in allegations that could see their...
Via
Benzinga
More Than Half Of Americans Want New COVID-19 Booster, But Ron DeSantis Will Fight Virus With His Charisma Alone
September 15, 2023
New COVID-19 boosters have been approved by the U.S. FDA in the fight against new variants. A new survey showed how likely people are to get new boosters and if they will have their children get...
Via
Benzinga
Exposures
COVID-19
Product Safety
Sandoz Pushes Product Launch Plans As Novartis Shareholders Approve The Spin-Off
September 15, 2023
At an Extraordinary General Meeting, Novartis AG's (NYSE: NVS) shareholders
Via
Benzinga
The 3 Most Undervalued Pharma Stocks to Buy in September 2023
September 14, 2023
Investing in pharmaceutical industry always carries risk, but several pharma stocks have an attractive risk/reward valuation right now.
Via
InvestorPlace
Alnylam Pharma Tumbles After FDA Advisors Dash Its Hopes Of Rivaling Pfizer
September 14, 2023
Its heart disease drug could gain approval, but FDA advisors don't expect it to take on Pfizer's leading drug.
Via
Investor's Business Daily
Exposures
Product Safety
Want to Collect $500 in Dividends Every Month? Invest $90,000 in These 3 Stocks
September 14, 2023
These stocks offer some mouth-watering payouts.
Via
The Motley Fool
This Market Could Be Worth $10 Billion by 2030 -- 2 Stocks to Buy Now
September 14, 2023
This market is currently in its infancy.
Via
The Motley Fool
Despite FDA Doubts, Adcomm Backs Alnylam's Gene Silencing Therapy For Expanded Use Into Rare Heart Disease
September 14, 2023
On Wednesday, an FDA advisory committee voted 9-3 in favor of Alnylam Pharmaceuticals Inc's (NASDAQ: ALNY) patisiran.
Via
Benzinga
Exposures
Product Safety
Mainz Biomed Paves The Way For Early Colorectal Cancer Diagnosis And Even Prevention
September 13, 2023
By the words of Dr. Ruediger Dahlke, cancer is a caricature of today’s modern society as it reflects the dark side ‘growth’. Our civilization is clearly more on the dark side of growth with technology...
Via
Benzinga
Europe Set To Launch Anti-Subsidy Probe Into Chinese EVs, American Airlines and Spirit Lower Profit Outlook, Manchester United's New Shirt Sponsor: Today's Top Stories
September 13, 2023
Financial Times Europe Set To Launch Anti-Subsidy Probe Into Chinese Electric Vehicles
Via
Benzinga
Say Goodbye to Free COVID-19 Shots: CDC Approves Priced Boosters for Omicron Subvariants
September 13, 2023
The Centers for Disease Control and Prevention (CDC) has officially endorsed COVID-19 booster shots for individuals six months and older as we approach the fall season.
Via
Benzinga
Exposures
COVID-19
Moderna Stock Has Been Beaten Up; Why The CFO Says Its Story Is 'Misunderstood'
September 13, 2023
Moderna unveiled promising results in flu on Wednesday, adding to its respiratory suite.
Via
Investor's Business Daily
3 Overlooked High-Yield Stocks Trading at a P/E of Less Than 10
September 12, 2023
These are the undervalued high-yield stocks to buy and hold for robust total returns in the next 24 months.
Via
InvestorPlace
The 3 Most Undervalued Biotech Stocks to Buy in September 2023
September 12, 2023
While these undervalued biotech stocks have struggled of late, they could surprise investors and prove to be long-term winners.
Via
InvestorPlace
NY Consulting Firm Predicts Psychedelic Drugs Market Will Generate Over $12B In Next 12 Years
September 12, 2023
NY-based strategic consulting firm Research Nester launched global market research for psychedelic substances with projections until 2035.
Via
Benzinga
DraftKings Apologizes For 9/11 'Never Forget' Parlay Promotion, Apple Set For Selling 'Made In India' iPhone 15 on Launch Day, MGM Resorts Faces Ongoing Cyber Incident: Today's Top Stories
September 12, 2023
Benzinga
Via
Benzinga
Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference
September 12, 2023
From
Pfizer Inc.
Via
Business Wire
Wall Street Has Found Its Next High-Flying Stock-Split Stock. Here's Why I'm Not Buying the Hype.
September 12, 2023
Nvidia, Amazon, DexCom, Shopify, Alphabet, Tesla, Palo Alto Networks, and Monster Beverage have all split their shares since July 2021. Next week, another industry leader will join this exclusive...
Via
The Motley Fool
Tesla, Oracle, Novavax, DraftKings, Pfizer: Why These Five Stocks Are Tending Today
September 11, 2023
U.S. stocks showcased a positive momentum as the trading day approached its end. The Nasdaq Composite exhibited a notable rise, gaining more than 1% on Monday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Pound for Pound: 3 Buzzworthy Drug Stocks Worth Their Weight in Gold
September 11, 2023
Investors looking for exposure to a booming business should hitch their wagons to one of these leading pharmaceutical companies.
Via
InvestorPlace
Moderna, Pfizer Get FDA Nod For Omicron COVID Boosters While Novavax Waits
September 11, 2023
The U.S.
Via
Benzinga
Exposures
COVID-19
Product Safety
Novavax Dives As Pfizer, Moderna Snag First Nods For Covid Boosters
September 11, 2023
Novavax says it's working with the FDA to answer final requests as part of the agency's review.
Via
Investor's Business Daily
Exposures
COVID-19
Product Safety
< Previous
1
2
...
29
30
31
32
33
34
35
36
37
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.